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An association between cardiovascular autonomic neuropa-
thy (CAN) and mortality among individuals with diabetes is 
known.1,2 However, the pathophysiology of this association 
is still under discussion. Silent myocardial ischemia is common 
in diabetics with CAN. Both parasympathetic and sympathetic 
pathways may be involved.3 There are data suggesting that 
the extent of coronary calcifi cation and the development of 
ischemic heart disease seem to be closely related to diabetic 
complications.4 The present study was aimed at investigating 
the degree of coronary artery calcifi cation in type 2 diabetes 
mellitus individuals (T2DMs) with CAN (WCAN; n = 9) and 
without CAN (WOCAN; n = 9). 
A pilot study was conducted on 18 T2DMs, using the fol-
lowing inclusion criteria: diabetes diagnosed more than 10 years 
earlier (TDDM), normal resting electrocardiogram, non-smok-
ing and being asymptomatic for coronary artery disease. The 
exclusion criteria were drug use for hyperlipidemia, glomerular 
fi ltration rate lower than 50 ml/min, congestive heart failure 
and history of stroke. Informed written consent was obtained 
from all patients and the Ethics Board of Universidade Federal 
de São Paulo had previously approved the protocol. 
Fasting serum C-peptide (normal value): 0.36-3.4 ng/ml), 
HbA1c (A1c Hemoglobin; normal value: 3.4-6.8%), lipids and 
urinary albumin/creatinine ratio were measured by standard 
laboratory tests. Arterial hypertension and electrocardiogram 
(EKG) (Marquette MAC500) were also evaluated. Electron 
beam computed tomography imaging was performed using an 
ultrafast scanner (C-150 Imatron) and the coronary calcium 
score (CaS) was calculated using Agatston’s method.5 The CAN 
diagnosis was based on two or more abnormal cardiovascular 
autonomic tests on two different occasions. These tests were, 
fi rstly, the heart rate variability (HRV) at six deep breaths per 
minute (mean); secondly the 30:15 ratio appraised for the re-
lationship between the longest RR interval of EKG around the 
thirtieth beat and the shortest interval around the fi fteenth beat 
after the patient was standing; and fi nally, the orthostatic hypo-
tension that was present when systolic blood pressure decreased 
by at least 20 mmHg in the third minute of standing. 
The differences between WCAN and WOCAN were 
analyzed using the Mann-Whitney or Student t test. The sig-
nifi cance level chosen was 0.05 for all statistical tests. 
The two groups did not differ in relation to: sex (males: 
44.4% versus 55.5%), age (54.7 ± 5.5 versus 59.2 ± 3.9 years), 
TDDM (14.4 ± 4.0 versus 13.7 ± 2.9 years), body mass index 
(28.2 ± 2.9 versus 27.6 ± 4.0 kg/m2), hypertension (88.9% 
versus 100%), albuminuria (55.6% versus 55.6%), high-den-
sity lipoprotein (1.36 ± 0.35 versus 1.06 ± 0.29 mmol/l), low-
density lipoprotein (3.30 ± 0.81 versus 3.36 ± 1.14 mmol/l), 
triglyceride (1.65 ± 0.83 versus 2.11 ± 0.48 mmol/l), basal 
C-peptide (0.59 ± 0.33 versus 0.74 ± 0.73 nmol/l) and HbA1c 
(9.0 ± 1.3 versus 8.2 ± 1.5%). However, the coronary CaS 
in WCAN (565.0; 225.9 - 805.5) was signifi cantly higher 
(p = 0.01) than in WOCAN (74.5; 6.6 - 221.8).
Therefore, despite the small number of individuals in this pilot 
study, the results suggest that even in T2DMs with similar clinical 
and metabolic characteristics, coronary calcifi cation is more preva-
lent when CAN is present. Some points regarding this association 
had been shown in other studies.6,7 However, greater numbers of 
subjects and long-term follow-up would help in determining the 
true association between CaS and CAN and its value in predicting 
coronary heart disease events in Type 2 diabetes. 
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